JOURNAL ARTICLE

Clinical implication of p53 overexpression in breast cancer patients younger than 50 years with a triple-negative subtype who undergo a modified radical mastectomy

Dong-Soo Lee, Sung Hwan Kim, Young Jin Suh, Suzy Kim, Hoon Kyo Kim, Byoung Yong Shim
Japanese Journal of Clinical Oncology 2011, 41 (7): 854-66
21719749

OBJECTIVE: The purpose of this study was to identify the clinicopathological characteristics and prognostic value of p53 overexpression in breast cancer patients treated with a modified radical mastectomy.

METHODS: The medical records of 197 patients who had undergone modified radical mastectomy between January 1991 and December 2008 were reviewed retrospectively. Breast cancer subtype and p53 overexpression were investigated using immunohistochemistry and/or fluorescent in situ hybridization analysis of surgical specimens.

RESULTS: The median follow-up after the modified radical mastectomy was 56.1 months (range, 14.7-232.7). The median age was 47 years (range, 31-72). p53 overexpression was noted in 73 patients (37.1%). Breast cancer-specific death rate (P = 0.011), cancer progression (P = 0.024), distant metastasis (P = 0.015), hormone receptor negativity (P < 0.001) and human epidermal growth factor receptor 2 positivity (P = 0.017) were detected more frequently in patients with p53 overexpression. The overall survival rates were significantly lower in the p53-overexpression group than in the non-p53-overexpression group (P = 0.021, log-rank test). In the multivariate analysis, p53 overexpression showed the strongest prognostic significance in patients aged <50 years (P = 0.039) and with the triple-negative subtype (P = 0.023).

CONCLUSIONS: p53 overexpression correlated with breast cancer-specific death rates and adverse prognostic factors in patients treated with modified radical mastectomy. p53 overexpression might be a more reliable prognosticator in patients aged <50 years and with the triple-negative subtype. More effective systemic treatments might be warranted for these patients exhibiting p53 overexpression. Further validation is required to make more definite conclusions.

Full Text Links

Find Full Text Links for this Article

Discussion

You are not logged in. Sign Up or Log In to join the discussion.

Related Papers

Remove bar
Read by QxMD icon Read
21719749
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"